These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 30243011

  • 1. The adipokine Chemerin and Fetuin-A Serum Levels in Type 2 Diabetes Mellitus: Relation to Obesity and Inflammatory Markers.
    El-Deeb TS, Bakkar SM, Eltoony L, Zakhary MM, Kamel AA, Nafee AM, Hetta HF.
    Egypt J Immunol; 2018 Jan; 25(1):191-202. PubMed ID: 30243011
    [Abstract] [Full Text] [Related]

  • 2. Relationship of serum novel adipokine chemerin levels with body composition, insulin resistance, dyslipidemia and diabesity in Saudi women.
    Habib SS, Eshki A, AlTassan B, Fatani D, Helmi H, AlSaif S.
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1296-1302. PubMed ID: 28387898
    [Abstract] [Full Text] [Related]

  • 3. Association of serum chemerin and inflammatory factors with type 2 diabetes macroangiopathy and waist-to-stature ratio.
    Yang M, Zhou X, Xu J, Yang B, Yu J, Gong Q, Zhang X, Sun X, Zhang Q, Xia J, Li J.
    Bosn J Basic Med Sci; 2019 Nov 08; 19(4):328-335. PubMed ID: 31078135
    [Abstract] [Full Text] [Related]

  • 4. Serum Chemerin Levels Are Associated with Abdominal Visceral Fat in Type 2 Diabetes.
    Han J, Kim SH, Suh YJ, Lim HA, Shin H, Cho SG, Kim CW, Lee SY, Lee DH, Hong S, Kim YS, Nam MS.
    J Korean Med Sci; 2016 Jun 08; 31(6):924-31. PubMed ID: 27247502
    [Abstract] [Full Text] [Related]

  • 5. [Relationship of serum Chemerin to obesity and type 2 diabetes mellitus].
    Wang LY, Wei L, Yu HY, Zhang Y, Jia WP.
    Zhonghua Yi Xue Za Zhi; 2009 Feb 03; 89(4):235-8. PubMed ID: 19552838
    [Abstract] [Full Text] [Related]

  • 6. Serum fetuin-A levels in obese and non-obese subjects with and without type 2 diabetes mellitus.
    Zhou ZW, Ju HX, Sun MZ, Chen HM, Fu QP, Jiang DM.
    Clin Chim Acta; 2018 Jan 03; 476():98-102. PubMed ID: 29174342
    [Abstract] [Full Text] [Related]

  • 7. Role of multifunctional Chemerin in obesity and preclinical diabetes.
    Fatima SS, Butt Z, Bader N, Pathan AZ, Hussain S, Iqbal NT.
    Obes Res Clin Pract; 2015 Jan 03; 9(5):507-12. PubMed ID: 25666091
    [Abstract] [Full Text] [Related]

  • 8. [Correlation of serum omentin-1 and chemerin with gestational diabetes mellitus].
    Pan BL, Ma RM.
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Aug 20; 36(9):1231-1236. PubMed ID: 27687656
    [Abstract] [Full Text] [Related]

  • 9. Increased Serum Chemerin Levels in Diabetic Retinopathy of Type 2 Diabetic Patients.
    Du J, Li R, Xu L, Ma R, Liu J, Cheng J, Zhang Z, Sun H.
    Curr Eye Res; 2016 Aug 20; 41(1):114-20. PubMed ID: 25848840
    [Abstract] [Full Text] [Related]

  • 10. Serum fetuin A and chemerin levels correlate with hepatic steatosis and regional adiposity in maintenance hemodialysis patients.
    Chen HY, Lin CC, Chiu YL, Hsu SP, Pai MF, Yang JY, Peng YS.
    PLoS One; 2012 Aug 20; 7(7):e38415. PubMed ID: 22815691
    [Abstract] [Full Text] [Related]

  • 11. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
    Yang S, Wang Q, Huang W, Song Y, Feng G, Zhou L, Tan J.
    Gynecol Endocrinol; 2016 Aug 20; 32(1):38-41. PubMed ID: 26291816
    [Abstract] [Full Text] [Related]

  • 12. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes.
    Weigert J, Neumeier M, Wanninger J, Filarsky M, Bauer S, Wiest R, Farkas S, Scherer MN, Schäffler A, Aslanidis C, Schölmerich J, Buechler C.
    Clin Endocrinol (Oxf); 2010 Mar 20; 72(3):342-8. PubMed ID: 19558533
    [Abstract] [Full Text] [Related]

  • 13. Chemerin and apelin are positively correlated with inflammation in obese type 2 diabetic patients.
    Yu S, Zhang Y, Li MZ, Xu H, Wang Q, Song J, Lin P, Zhang L, Liu Q, Huang QX, Wang K, Hou WK.
    Chin Med J (Engl); 2012 Oct 20; 125(19):3440-4. PubMed ID: 23044303
    [Abstract] [Full Text] [Related]

  • 14. Fenofibrate reduces inflammation in obese patients with or without type 2 diabetes mellitus via sirtuin 1/fetuin A axis.
    Noureldein MH, Abd El-Razek RS, El-Hefnawy MH, El-Mesallamy HO.
    Diabetes Res Clin Pract; 2015 Sep 20; 109(3):513-20. PubMed ID: 26105582
    [Abstract] [Full Text] [Related]

  • 15. Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity.
    Chakaroun R, Raschpichler M, Klöting N, Oberbach A, Flehmig G, Kern M, Schön MR, Shang E, Lohmann T, Dreßler M, Fasshauer M, Stumvoll M, Blüher M.
    Metabolism; 2012 May 20; 61(5):706-14. PubMed ID: 22136911
    [Abstract] [Full Text] [Related]

  • 16. Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes.
    Tönjes A, Fasshauer M, Kratzsch J, Stumvoll M, Blüher M.
    PLoS One; 2010 Nov 09; 5(11):e13911. PubMed ID: 21085476
    [Abstract] [Full Text] [Related]

  • 17. Hepatokines Fetuin-A and Fetuin-B status in obese Saudi patient with diabetes mellitus type 2.
    Almarashda O, Abdi S, Yakout S, Khattak MNK, Al-Daghri NM.
    Am J Transl Res; 2022 Nov 09; 14(5):3292-3302. PubMed ID: 35702137
    [Abstract] [Full Text] [Related]

  • 18. Serum Chemerin Levels are Associated with Visceral Adiposity, Independent of Waist Circumference, in Newly Diagnosed Type 2 Diabetic Subjects.
    Cheon DY, Kang JG, Lee SJ, Ihm SH, Lee EJ, Choi MG, Yoo HJ, Kim CS.
    Yonsei Med J; 2017 Mar 09; 58(2):319-325. PubMed ID: 28120562
    [Abstract] [Full Text] [Related]

  • 19. C-reactive protein, chemerin, fetuin-A and osteopontin as predictors of cardiovascular risks in persons with psoriasis vulgaris.
    Borsky P, Fiala Z, Andrys C, Beranek M, Hamakova K, Kremlacek J, Malkova A, Svadlakova T, Krejsek J, Palicka V, Rehacek V, Kotingova L, Borska L.
    Physiol Res; 2021 Jul 12; 70(3):383-391. PubMed ID: 33982577
    [Abstract] [Full Text] [Related]

  • 20. Serum levels of chemerin, apelin, vaspin, and omentin-1 in obese type 2 diabetic Egyptian patients with coronary artery stenosis.
    Motawi TMK, Mahdy SG, El-Sawalhi MM, Ali EN, El-Telbany RFA.
    Can J Physiol Pharmacol; 2018 Jan 12; 96(1):38-44. PubMed ID: 28957639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.